All > Cervical Spondylotic Myelopathy > Sci

Gentamicin Sulfate for Spinal Cord Injuries

Phase-Based Progress Estimates

Effectiveness

Safety

Spinal Cord Injuries+7 More

Gentamicin Sulfate - Drug

You have a chance of qualifying for this trial. We made sure your application will take less than 5 minutes.

Eligibility

18+

All Sexes

What conditions do you have?

Select

Eligibility

18+

All Sexes

What conditions do you have?

Select

Study Summary

This trial looks at whether a medication can help reduce urinary infections and complications in people with spinal cord injuries, as well as improve their quality of life.

Eligible Conditions

Spinal Cord Injuries
Spinal Cord Diseases
Urinary Tract Infections
Neurogenic Urinary Bladder

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Spinal Cord Injuries

Biweekly IV Gentamicin

Sildenafil Citrate

Lactobacillus RhamnosusGG

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 6 months

6 months

Neurogenic Urinary Bladder

Change in score of Neurogenic Bowel Dysfunction

Number of urinary tract infections (UTI)

Trial Safety

Safety Progress

2 of 3

This is further along than 68% of similar trials

Other trials for Spinal Cord Injuries

Biweekly IV Gentamicin

Sildenafil Citrate

Lactobacillus RhamnosusGG

Trial Design

1 Treatment Group

Gentamicin sulfate

1 of 1

Experimental Treatment

25 Total Participants · 1 Treatment Group

Primary Treatment: Gentamicin Sulfate · No Placebo Group · Phase 2 & 3

Gentamicin sulfate

Drug

Experimental Group · 1 Intervention: Gentamicin Sulfate · Intervention Types: Drug

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Gentamicin

FDA approved

Trial Logistics

Trial Timeline

Approximate Timeline

Screening: ~3 weeks

Treatment: Varies

Reporting: 6 months

Who is running the clinical trial?

University of MichiganLead Sponsor

1,616 Previous Clinical Trials

6,330,844 Total Patients Enrolled

15 Trials studying Spinal Cord Injuries

3,079 Patients Enrolled for Spinal Cord Injuries

Denise Tate, PhDPrincipal Investigator - University of Michigan

University of Michigan

Anne Pelletier-Cameron, MDPrincipal InvestigatorUniversity of Michigan

1 Previous Clinical Trials

24 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 8 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

You are able to perform daily instillation on self or with help of others and are willing to adhere to the study regiment.

You have a history of SCI or SCD with sustained neurological dysfunction.

You are using clean intermittent catheterization or catheterization through a stoma (i.e.

About The Reviewer

Michael Gill - B. Sc.

First Published: October 4th, 2021

Last Reviewed: October 18th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References